Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 Ann Intern Med
4 J Clin Invest
1 N Engl J Med
1 Osteoporos Int

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Intern Med

  1. ALIBHAI SMH, Zukotynski K, Walker-Dilks C, Emmenegger U, et al
    Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2017;167:341-350.
    PubMed     Text format     Abstract available

    J Clin Invest

  2. RAUCH F
    The brains of the bones: how osteocytes use WNT1 to control bone formation.
    J Clin Invest. 2017;127:2539-2540.
    PubMed     Text format     Abstract available

  3. JOENG KS, Lee YC, Lim J, Chen Y, et al
    Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis.
    J Clin Invest. 2017;127:2678-2688.
    PubMed     Text format     Abstract available

  4. BAE S, Lee MJ, Mun SH, Giannopoulou EG, et al
    MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRalpha.
    J Clin Invest. 2017;127:2555-2568.
    PubMed     Text format     Abstract available

    The many ways of osteoclast activation.
    J Clin Invest. 2017;127:2530-2532.
    PubMed     Text format     Abstract available

    N Engl J Med

  6. SAAG KG, Petersen J, Brandi ML, Karaplis AC, et al
    Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.
    N Engl J Med. 2017 Sep 11. doi: 10.1056/NEJMoa1708322.
    PubMed     Text format     Abstract available

    Osteoporos Int

  7. ANSARI H, Beaton DE, Sujic R, Rotondi NK, et al
    Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.
    Osteoporos Int. 2017 Sep 10. doi: 10.1007/s00198-017-4206.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.